Myelodysplastic Syndromes-Many New Drugs, Little Therapeutic Progress

被引：11
作者：
Tefferi, Ayalew [1 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
来源：
MAYO CLINIC PROCEEDINGS | 2010年 / 85卷 / 11期
关键词：
ACUTE MYELOID-LEUKEMIA; STEM-CELL TRANSPLANTATION; IRON CHELATION-THERAPY; HIGH-RISK; PHASE-III; PROGNOSTIC-FACTORS; SCORING SYSTEM; SERUM FERRITIN; UNITED-STATES; 5Q DELETION;
D O I：
10.4065/mcp.2010.0502
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1042 / 1045
页数：4
相关论文
共 50 条
[1]   Myelodysplastic syndromes: a review of therapeutic progress over the past 10 years [J].
Feld, Jonathan ;
Belasen, Abigail ;
Navada, Shyamala C. .
EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (06) :465-482
[2]   Progress in Myelodysplastic Syndromes [J].
Garcia-Manero, Guillermo .
CLINICAL LYMPHOMA & MYELOMA, 2009, 9 :S286-S292
[3]   Immunomodulatory Drugs: New Options for the Treatment of Myelodysplastic Syndromes [J].
Castelli, Roberto ;
Cassin, Ramona ;
Cannavo, Antonino ;
Cugno, Massimo .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (01) :1-7
[4]   Myelodysplastic Syndromes: A New Decade [J].
Volpe, Virginia O. ;
Garcia-Manero, Guillermo ;
Komrokji, Rami S. .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (01) :1-16
[5]   Current therapeutic approaches for patients with myelodysplastic syndromes [J].
Greenberg, Peter L. .
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (02) :131-143
[6]   Review of therapeutic options and the management of patients with myelodysplastic syndromes [J].
Ozcan, Mehmet A. ;
Ilhan, Osman ;
Ozcebe, Osman I. ;
Nalcaci, Meliha ;
Gulbas, Zafer .
EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (02) :165-189
[7]   Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances [J].
Thalambedu, Nishanth ;
Lal, Bhavesh Mohan ;
Harbaugh, Brent ;
Alapat, Daisy V. ;
Gaddam, Mamatha ;
Sanchez, Cesar Giancarlo Gentille ;
Kumaran, Muthu ;
Varma, Ankur .
CANCERS, 2025, 17 (03)
[8]   Therapeutic Modalities for Patients with Lower-Risk Myelodysplastic Syndromes: Current Options and Future Directions [J].
Navada, Shyamala C. ;
Silverman, Lewis R. .
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2011, 6 (01) :5-12
[9]   New therapeutic approaches in myelodysplastic syndromes: Hypomethylating agents and lenalidomide [J].
Loiseau, Clemenee ;
Ali, Ashfaq ;
Itzykson, Raphael .
EXPERIMENTAL HEMATOLOGY, 2015, 43 (08) :661-672
[10]   Myelodysplastic syndromes - diagnostic and therapeutic standards and new developments. [J].
Nolte, Florian ;
Hofmann, Wolf-K. .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (20) :1502-1507
12345